List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: Open Studies | "Measles"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Measles
Intervention: Biological: attenuated measles vaccine
2 Recruiting Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Conditions: Measles Disease;   Mumps Disease;   Rubella Disease;   Varicella Disease
Interventions: Biological: Priorix-Tetra TM (combined measles-mumps-rubella-varicella vaccine);   Biological: GSK Biologicals' 208136, new formulation
3 Recruiting Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: VarilrixTM;   Biological: PriorixTM;   Biological: GSK Biologicals' vaccine 208136
4 Recruiting Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Varilrix™;   Biological: Priorix™
5 Recruiting Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
Condition: Measles
Interventions: Biological: MVA-mBN85B;   Biological: Rouvax
6 Recruiting Ontogeny of Measles Immunity in Infants
Condition: Measles
Interventions: Biological: Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous);   Biological: MMR-II (Measles-Mumps-Rubella Virus Live Vaccine, 0.5ml subcutaneous)
7 Recruiting Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine
8 Not yet recruiting Measles, Mumps, and Rubella (MMR) Immunity in College Students
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine
9 Recruiting The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Conditions: Immunity;   Measles;   Mumps;   Rubella
Interventions: Dietary Supplement: Probiotics (L.acidophilus and B.lactis);   Dietary Supplement: Cornflor
10 Recruiting Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Condition: Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
Interventions: Biological: Havrix®;   Biological: Prevnar®;   Biological: M-M-R® II (Merck and Co);   Biological: Varivax®;   Biological: GSK Biological's investigational vaccine 209762
11 Recruiting Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Measles, Mumps, Rubella vaccination
12 Recruiting Randomized Study of Not Giving Diphteria-Tetanus-Pertussis Vaccination With or After Measles Vaccination
Conditions: Mortality;   Hospitalization;   Adverse Events
Intervention: Biological: DTP3+OPV3 and MV versus OPV3 and MV or DTP4+OPV4 versus OPV4
13 Recruiting IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: ROUVAX;   Biological: placebo
14 Recruiting Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: carcinoembryonic antigen-expressing measles virus;   Genetic: fluorescence in situ hybridization;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: needle biopsy;   Procedure: neoadjuvant therapy
15 Recruiting Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: carcinoembryonic antigen-expressing measles virus;   Genetic: reverse transcriptase-polymerase chain reaction
16 Recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter;   Drug: cyclophosphamide;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: biopsy
17 Recruiting Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Toddlers
Condition: Meningococcal Infections
Interventions: Biological: MenACWY and MMRV;   Biological: MMRV

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services